Sagimet Biosciences (SGMT) Other Accumulated Expenses (2022 - 2026)

Sagimet Biosciences' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $15000.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 6.25% year-over-year to $15000.0; the TTM figure through Mar 2026 stood at $15000.0 (down 6.25% YoY), while the FY2025 annual figure was $27000.0, up 440.0% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $15000.0, down from $27000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $233000.0 in Q4 2023, with the low at $1000.0 in Q2 2025.
• The 5-year median for Other Accumulated Expenses is $15500.0 (2025), against an average of $48416.7.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses plunged 97.85% in 2024, then soared 440.0% in 2025.
• Sagimet Biosciences' Other Accumulated Expenses stood at $57000.0 in 2022, then jumped by 308.77% to $233000.0 in 2023, then slumped by 97.85% to $5000.0 in 2024, then jumped by 440.0% to $27000.0 in 2025, then sank by 44.44% to $15000.0 in 2026.
• Business Quant data shows SGMT's Other Accumulated Expenses at $15000.0 in Q1 2026, $27000.0 in Q4 2025, and $8000.0 in Q3 2025.